pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
raps·1d ago·1 min read
save

Experts assess EU medical device and diagnostic regulations at RAPS Convergence 2026

Sep 16, 2026·read at raps ↗RegulatoryNeutral

A panel of experts representing the European Commission, industry groups and notified bodies gathered in Charlotte, North Carolina during RAPS Convergence 2026.

The group reviewed the current state of the EU Medical Device Regulation (MDR) and In Vitro Diagnostics Regulation (IVDR) as proposed reforms are considered.

Participants discussed implementation challenges, timelines and potential impacts on manufacturers and the broader healthcare market.

source

This writeup was produced by pharmadog from original reporting by raps.

Original headline: “Convergence: Experts review the state of play for MDR/IVDR amid proposed reforms”

read at raps ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Diagnostics Company2

related stories

  • Jul 20Tempus buys out cancer genomics partner Personalis in $1.5 billion dealFierce Biotech
  • Jul 20BMS expands AI footprint with Nvidia, aiming for ‘most powerful AI factory in life sciences’Fierce Biotech
  • Jul 19Abbott hit by cyberattack on cancer diagnostics, LabCentral portal businessesFierce Biotech
  • Jul 16STAT+: Medicare wants to shake up how it pays for clinical AISTAT
  • Jul 15STAT+: New study untangles how Epstein-Barr viral infection triggers immune response in multiple sclerosisSTAT